Form 10-K Coherus BioSciences, For: Dec 31
http://archive.fast-edgar.com/20150323/A3AZUG2CZ222NZB2222M2ZZ2QJUDZY22H572
Filed on: March 23, 2015
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
- /C O R R E C T I O N -- Rayence/
- InvestorNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Turns to AI to Advance Precision Oncology
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share